Drug Shows Promise for Post-Transplant New-Onset Diabetes Renal and Urology News Oral therapeutic options for treating hyperglycemia in these patients are limited because of reduced renal function, potential interactions with immunosuppressive drugs, and adverse effects such as hypoglycemic events that may increase cardiovascular ... |
